Dr. Mark oversees pharmacy services across 10 hospitals, nine outpatient pharmacies and 17 infusion centers, providing strategic and operational leadership for the entire network. In 2024, she exceeded financial goals by delivering $16.7 million in savings and revenue optimization through targeted initiatives. She has driven operational excellence by standardizing technologies such as BD devices, IV and PCA pumps, and Omnicell systems, as well as leading major pharmacy construction projects. Under her guidance, clinical pharmacy services have expanded significantly, including ambulatory care, wellness clinics, anticoagulation, prior authorization, refill management and medication governance programs. A strong advocate for safety and compliance, she ensures adherence to regulatory standards, including 340B program requirements, while championing formulary management and protocol development. In addition to her operational impact, Dr. Mark mentors pharmacy residents, supports educational partnerships and serves on the dean’s advisory board at Duquesne University.
